Paul Bleicher, M.D., Ph.D., is the chief executive officer of OptumLabs, a health care research and innovation center. Prior to his current role, Dr. Bleicher was chief medical officer for Humedica, a next-generation clinical informatics company that was acquired by Optum in January 2013. In that role, he was involved in all aspects of medical informatics, data analytics privacy and regulatory compliance, and product development.

From 1997 to 2008 he founded Phase Forward, a leading provider of clinical trial data management and drug safety software, where he helped grow the organization from a concept to a publicly-traded company until its acquisition in 2010 by Oracle Corporation.